As a reminder to this well informed board but perhaps more directed to Jeff Murray, here is the link to the published study on the Montefiore patients. Included is a grid for each patient and their co-morbidities and key clinical parameters. There were 6 renal transplant patients including 8 that were on dialysis, 8 of the 10 were on pressor agents, and 7 were intubated. The study itself under Methods references the following, emphasis “critical”. Six of these patients survived the study period at a time NYC saw an 86% mortality rate. Jeff? Bueller? Hello!!!!!
“In March 2020, 10 terminally ill, critical COVID-19 patients received two doses of leronlimab via individual emergency use indication.”